The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Is The Market Size Of The Antimicrobial Resistance Diagnostics Market Expected To Change Between 2026 And 2030?
The antimicrobial resistance diagnostics market has demonstrated robust growth in recent years. It is projected to expand from $4.41 billion in 2025 to $4.74 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.5%. This growth observed in the historical period can be ascribed to the increasing prevalence of antibiotic-resistant infections, the reliance on conventional culture-based diagnostics, a rise in hospital-acquired infections, growing awareness of antimicrobial stewardship, and the expansion of clinical microbiology laboratories.
The antimicrobial resistance diagnostics market size is anticipated to undergo significant expansion in the coming years. This market is projected to reach $6.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. The expected growth during the forecast period is driven by advancements in PCR and NGS diagnostic technologies, increased government funding for AMR surveillance programs, the rising adoption of rapid diagnostic tests, growth within pharmaceutical and biotechnology research, and the integration of data-driven decision support tools. Prominent trends for the forecast period include the increasing uptake of rapid and point-of-care AMR diagnostics, a growing demand for targeted and personalized antimicrobial therapy, enhanced surveillance of drug-resistant pathogens, the expansion of molecular and genomic-based diagnostic testing, and the strengthening of hospital infection control and stewardship programs.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25696&type=smp
Which Major Factors Are Driving The Expansion Of The Antimicrobial Resistance Diagnostics Market?
The growing occurrence of drug-resistant infections is anticipated to drive the expansion of the antimicrobial resistance diagnostics market. These infections develop when bacteria, viruses, fungi, or parasites adapt ways to withstand medications that were once effective, rendering conventional treatments useless and infections more challenging to manage. The increasing spread of drug-resistant infections stems from the excessive use of antibiotics in agriculture, where low-dose antimicrobials are commonly incorporated into animal feed, fostering resistance that can transfer to humans via the food chain. Antimicrobial resistance diagnostics, including rapid genetic assays and culture-based sensitivity tests, are essential in combating the rising incidence of drug-resistant infections. They achieve this by allowing for prompt identification of resistant pathogens, directing precise treatments, and lessening the inappropriate use of broad-spectrum antibiotics. As an illustration, in November 2024, the UK Health Security Agency (UKHSA), a UK-based government agency, stated that the count of serious antibiotic-resistant infections in England climbed from 58,224 in 2022 to an estimated 66,730 in 2023. Concurrently, antibiotic consumption rose by 2.4% in 2023 compared to 2022. Consequently, the escalating prevalence of drug-resistant infections is a key factor propelling the expansion of the antimicrobial resistance diagnostics market.
How Is The Antimicrobial Resistance Diagnostics Market Structured Across Different Segments?
The antimicrobial resistance diagnostics market covered in this report is segmented –
1) By Product Type: Kits And Reagents, Instruments And Consumables
2) By Pathogen: Drug-Resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Campylobacter (DRC), Clostridium Difficile (CD), Methicillin Resistant Staphylococcus Aureus (MRSA), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRntS), Other Pathogens
3) By Technology: Microbiology Culture, Immunoassay, PCR (Polymerase Chain Reaction), NGS (Next-Generation Sequencing), Mass Spectrometry, Rapid And Point Of Care, Other Technologies
4) By End-User: Hospitals And Clinics, Diagnostics Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Kits And Reagents: Deoxyribonucleic Acid (DNA) Extraction Kits, Ribonucleic Acid (RNA) Extraction Kits, Polymerase Chain Reaction (PCR) Reagents, Immunoassay Reagents, Stains And Dyes, Culture Media
2) By Instruments And Consumables: Polymerase Chain Reaction (PCR) Machines, Ultraviolet-Visible (UV-Vis) Spectrophotometers, Next-Generation Sequencing (NGS) Systems, Microarray Scanners, Automated Liquid Handlers, Sample Collection Tubes And Swabs
Which Trends Are Shaping The Future Of The Antimicrobial Resistance Diagnostics Market?
Companies operating in the **antimicrobial resistance (AMR) diagnostics market** are strategically using innovative technologies, such as **point-of-care antimicrobial-susceptibility testing (AST) technologies**, to enhance diagnostic speed, precision, and the effectiveness of antimicrobial stewardship programs. **Point-of-care antimicrobial-susceptibility testing (AST)** refers to quick tests conducted near the patient that determine which antibiotics are effective against an infection, enabling clinicians to rapidly choose targeted and effective treatments. For example, in **June 2023**, **Sysmex Corporation**, a Japan-based provider of in-vitro diagnostic solutions, launched the **PA-100 AST System**. This platform is a rapid, point-of-care AST system designed to detect bacterial presence and ascertain antimicrobial susceptibility in urine samples within approximately **30 minutes**. The system includes microfluidic single-cell analysis, near-patient testing capabilities, and automated reporting of susceptibility outcomes. The **PA-100 AST System** improves clinical decision-making, helps reduce unnecessary antibiotic prescriptions, and supports timely, targeted therapies to combat antimicrobial resistance.
Which Major Players Dominate The Antimicrobial Resistance Diagnostics Market?
Major companies operating in the antimicrobial resistance diagnostics market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Becton Dickinson And Company, bioMerieux SA, Sysmex Corporation, Bio Rad Laboratories Inc, QIAGEN NV, Seegene Inc, Alifax S r l, Accelerate Diagnostics Inc, Molsid SAS, Genetic Signatures Limited, iFAST Diagnostics Ltd, Astek Diagnostics Inc, OpGen Inc, T2 Biosystems, Jiangsu Medomics Medical Technology Co Ltd, Cepheid, Luminex Corporation, Bruker Corporation, Hologic Inc
Read the full antimicrobial resistance diagnostics market report here:
Which Region Currently Holds The Largest Share Of The Antimicrobial Resistance Diagnostics Market?
North America was the largest region in the antimicrobial resistance diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Antimicrobial Resistance Diagnostics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25696&type=smp
Browse Through More Reports Similar to the Global Antimicrobial Resistance Diagnostics Market 2026, By The Business Research Company
Sleep Apnea Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/sleep-apnea-devices-global-market-report
Sleep Tech Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/sleep-tech-devices-global-market-report
Sinus Dilation Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/sinus-dilation-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model